SummaryThe effect of L-deprenyl in combination with L-Dopa was studied in 22 Parkinsonian patients, with various forms of "on-off" phenomena. L-deprenyl is a selective, irreversible inhibitor of monoamine oxidase type B, without tyramine potentiating property. The results were very encouraging with regard to amelioration of "on-off effect". More than 80% of the patients with nocturnal akinesia, early morning akinesia, end-of-dose akinesia and non-dose-dependent akinesia, showed improvement. In 9 out of 22 patients, the "off" period disappeared. The platelet monoamine oxidase activity, which is of type B and similar to the brain enzyme, was fully inhibited by the daily dose of L-deprenyl. There was no significant change in serum prolactin level during the duration of 6 weeks' treatment with L-deprenyl.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.